{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:58:09Z","timestamp":1792195089856,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020300","name":"Lembaga Penelitian dan Pengabdian kepada Masyarakat, Universitas Riau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008463","name":"Airlangga University","doi-asserted-by":"publisher","award":["1031\/UN3.15\/PT\/2021"],"award-info":[{"award-number":["1031\/UN3.15\/PT\/2021"]}],"id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e39002","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T23:05:07Z","timestamp":1728083107000},"page":"e39002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression of interferon-stimulated genes, but not polymorphisms in the interferon \u03b1\/\u03b2 receptor 2 gene, is associated with coronavirus disease 2019 mortality"],"prefix":"10.1016","volume":"10","author":[{"given":"Berliana","family":"Hamidah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cennikon","family":"Pakpahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laksmi","family":"Wulandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damayanti","family":"Tinduh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri","family":"Wibawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cita Rosita Sigit","family":"Prakoeswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-6491","authenticated-orcid":false,"given":"Delvac","family":"Oceandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e39002_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608645","article-title":"Importance of type I and III interferons at respiratory and intestinal barrier surfaces","volume":"11","author":"Stanifer","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: what do they all do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.heliyon.2024.e39002_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.605087","article-title":"Decreased type I interferon production by plasmacytoid dendritic cells contributes to severe dengue","volume":"11","author":"Upasani","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.27277","article-title":"Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway","volume":"60","author":"Shirasaki","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e39002_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.abd2208","article-title":"Interferon responses in viral pneumonias","volume":"369","author":"Grajales-Reyes","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e39002_bib7","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1038\/s41598-024-55696-0","article-title":"Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-alpha","volume":"14","author":"Queiroz","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e39002_bib8","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","author":"Sposito","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e39002_bib9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e39002_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e39002_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e39002_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e39002_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","article-title":"Dual nature of type I interferons in SARS-CoV-2-induced inflammation","volume":"42","author":"King","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e39002_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.heliyon.2024.e39002_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e39002_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12964-022-00903-6","article-title":"A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients","volume":"20","author":"Soltani-Zangbar","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.heliyon.2024.e39002_bib19","series-title":"Clinical Management of COVID-19","year":"2020"},{"key":"10.1016\/j.heliyon.2024.e39002_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40246-021-00330-7","article-title":"Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients","volume":"15","author":"Wulandari","year":"2021","journal-title":"Hum. Genom."},{"key":"10.1016\/j.heliyon.2024.e39002_bib21","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkr1013","article-title":"PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update","volume":"40","author":"Wang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e39002_bib22","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e39002_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.heliyon.2024.e39002_bib24","series-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines","year":"2020"},{"key":"10.1016\/j.heliyon.2024.e39002_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.heliyon.2024.e39002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22997","article-title":"Insights on interferon-independent induction of interferon-stimulated genes shaping the lung's response in early SARS-CoV-2 infection","volume":"9","author":"Cho","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e39002_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003566","article-title":"High trans-ethnic replicability of GWAS results implies common causal variants","volume":"9","author":"Marigorta","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.heliyon.2024.e39002_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9551163","article-title":"Association of IFNAR2 rs2236757 and OAS3 rs10735079 polymorphisms with susceptibility to COVID-19 infection and severity in Palestine","volume":"2023","author":"Abdelhafez","year":"2023","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.heliyon.2024.e39002_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/genes14010029","article-title":"Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19","volume":"14","author":"Dieter","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.heliyon.2024.e39002_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949413","article-title":"IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19","volume":"13","author":"Fricke-Galindo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39002_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.advms.2024.03.007","article-title":"Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort","volume":"69","author":"Skerenova","year":"2024","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e39002_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/genes13101884","article-title":"Host genetic risk factors associated with COVID-19 susceptibility and severity in Vietnamese","volume":"13","author":"Nhung","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.heliyon.2024.e39002_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13054-023-04388-8","article-title":"Polymorphism in interferon alpha\/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19","volume":"27","author":"Jalkanen","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2024.e39002_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.heliyon.2024.e39002_bib36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e39002_bib37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened innate immune responses in the respiratory tract of COVID-19 patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.heliyon.2024.e39002_bib38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e39002_bib39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e39002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100478","article-title":"A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-kappa plus TFF2 in patients with moderate COVID-19","volume":"25","author":"Fu","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.heliyon.2024.e39002_bib41","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024150335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024150335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:50:33Z","timestamp":1789822233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024150335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":41,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024150335"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39002","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of interferon-stimulated genes, but not polymorphisms in the interferon \u03b1\/\u03b2 receptor 2 gene, is associated with coronavirus disease 2019 mortality","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39002"}}